Schedule III is half official. On April 22, Acting AG Todd Blanche signed a thirty-four-page order rescheduling FDA-approved marijuana and state medical cannabis under treaty authority. The rest of cannabis gets a six-week hearing in Arlington. The industry is toasting a meal that was never served. What AG Order 6754-2026 actually did, what it didn't, and what cannabis testing labs should be doing this week before federal scrutiny arrives with a return address.